Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
44 studies found for:    elad
Show Display Options
Rank Status Study
1 Withdrawn Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)
Condition: Fulminant Hepatic Failure
Interventions: Other: Standard of Care;   Device: ELAD®
2 Completed Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency
Conditions: Acute Hepatitis;   Chronic Hepatitis
Interventions: Biological: ELAD plus standard of care treatment;   Other: Standard of care treatment
3 Completed Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
Condition: Acute Alcoholic Hepatitis
Interventions: Biological: ELAD treatment;   Other: Standard of care (Control)
4 Terminated Safety and Efficacy of ELAD to Treat Acute Liver Failure (ALF)
Conditions: Acute Liver Failure;   Fulminant Hepatic Failure;   Primary Graft Non-Function;   Surgically-Induced Liver Failure
Intervention: Biological: ELAD
5 Recruiting Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
Condition: Acute Alcoholic Hepatitis
Interventions: Biological: ELAD System;   Other: Standard of Care (Control)
6 Terminated Study to Assess Safety and Efficacy of ELAD in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure
Condition: Severe Acute Alcoholic Hepatitis
Interventions: Biological: ELAD;   Other: Standard of Care treatment
7 Completed Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis
Condition: Acute On Chronic Hepatitis
Interventions: Biological: ELAD plus standard of care treatment;   Other: Standard of care
8 No longer available Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery
Condition: Liver Failure
Intervention: Device: ELAD®
9 Completed Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure
Condition: Fulminant Hepatic Failure
Interventions: Biological: ELAD;   Other: Standard of care (Control)
10 Recruiting Evaluating Liraglutide in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Liraglutide;   Drug: Placebo
11 Withdrawn Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion
Condition: Acute Liver Failure
Intervention: Drug: ELAD (Extracorporeal Liver Assist System)
12 Recruiting Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration
Conditions: Inhibition (Psychology);   Schizophrenia;   Medication Adherence
Interventions: Device: PPI monitoring device protocol;   Other: Questionnaires
13 Completed Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography
Conditions: Atrial Fibrillation;   Atrial Flutter
Intervention: Device: Intracardiac Imaging
14 Recruiting Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Conditions: Atrial Fibrillation;   Obstructive Sleep Apnea;   Cardiac Arrhythmias
Intervention: Device: Home Sleep Testing Device
15 Recruiting Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients
Conditions: Acute Coronary Syndromes;   ST Elevation Myocardial Infarction
Interventions: Drug: Chewing Ticagrelor;   Drug: Oral Ticagrelor
16 Completed Efficacy Study Image Guided, Auto-Targeted Neurostimulation for the Treatment of Non-Specific Low Back Pain
Condition: Low Back Pain
Intervention: Device: Image Guided TENS (Auto-Targeted Neurostimulation, NeMa-st)
17 Recruiting Clinical Study of the TSP Crosser System for Transseptal Access and Left Atrial Catheter Navigation
Condition: Atrial Fibrillation
Intervention: Device: TSP Crosser Transseptal Access System
18 Completed Induction of Labor in Patients With Unfavorable Cervical Conditions
Condition: Unfavorable Cervix for Induction of Labor
Interventions: Device: ARD (Atad Ripener Device);   Device: AID (Atad double balloon Instillation Device);   Device: folly catheter
19 Recruiting T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies
Conditions: Acute Lymphoblastic Leukemia, B-precursor;   Non-Hodgkin Lymphoma, B-cell
Intervention: Biological: CD19 CAR T cells
20 Recruiting The Effect of Complementary Medicine (CAM) Treatments on Common Symptoms in Hospitalized Patients
Conditions: Pain;   Nausea;   Anxiety
Intervention: Other: CAM treatments

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.